Neuland Labs Guides Upto 2x Asset Turnover For Hyderabad Facility: CEO Saharsh Davuluri
CNBC-TV18 · 24 Sept 2026 · 2 min
Management interview of Neuland Laboratories Ltd (NEULANDLAB), with 4 key numbers discussed.
- Saharsh Davuluri, CEO, Neuland Laboratories Ltd
Neuland Labs has recently commissioned a new facility representing a near $30mn investment, with module one accounting for about $20mn. Two clinical-stage projects are expected to occupy most of the module one capacity. CEO Saharsh Davuluri considers an asset turn of 1.5 to 2 times a reasonable estimate for module one, compared to the overall company asset turn of 2.5 times. Final revenue potential will depend on the commercial success of the innovators' products.